SBC Medical Group Holdings Incorporated (SBC)

NASDAQ: SBC · Real-Time Price · USD

3.056

+0.055 (1.85%)

At close: Jun 18, 2026, 4:00 PM EDT

3.070

+0.014 (0.47%)

After-hours: Jun 18, 2026, 4:10 PM EDT

SBC Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	169.34	173.61	205.42	193.54	174.16
Revenue Growth (YoY)	-14.45%	-15.48%	6.13%	11.13%	-
Cost of Revenue	49.44	46.32	49.37	56.24	59.33
Gross Profit	119.9	127.28	156.05	137.3	114.83
Selling, General & Admin	58.89	59.8	57.67	66.23	70.65
Other Operating Expenses	-	-	28.08	0.41	24.06
Total Operating Expenses	58.89	59.8	85.75	66.64	94.72
Operating Income	61	67.49	70.3	70.66	20.12
Interest Income	0.26	0.2	0.02	0.09	0.47
Interest Expense	-0.27	-0.16	-0.03	-0.05	-0.03
Other Non-Operating Income (Expense)	10.3	14.54	3.16	2.88	3.12
Total Non-Operating Income (Expense)	10.3	14.58	3.15	2.92	3.56
Pretax Income	69.47	82.07	73.46	73.58	23.68
Provision for Income Taxes	28.59	31.02	26.77	35.02	18.12
Net Income	40.88	51.05	46.69	38.56	5.55
Minority Interest in Earnings	0.09	0.06	0.08	-0.81	-0.76
Net Income to Common	40.79	50.99	46.61	39.37	6.32
Net Income Growth	-17.36%	9.38%	18.40%	523.44%	-
Shares Outstanding (Basic)	103	103	97	94	8
Shares Outstanding (Diluted)	103	103	97	94	8
Shares Change (YoY)	4.04%	6.67%	2.51%	1084.96%	-
EPS (Basic)	0.39	0.50	0.48	0.42	0.79
EPS (Diluted)	0.39	0.50	0.48	0.42	0.79
EPS Growth	-22.00%	4.17%	14.29%	-46.84%	-
Free Cash Flow	29.81	22.3	17.17	41.15	-24.99
Free Cash Flow Growth	33.68%	29.84%	-58.26%	-	-
Free Cash Flow Per Share	0.29	0.22	0.18	0.44	-3.14
Gross Margin	70.80%	73.32%	75.97%	70.94%	65.94%
Operating Margin	36.02%	38.87%	34.23%	36.51%	11.55%
Profit Margin	24.14%	29.40%	22.73%	19.92%	3.19%
FCF Margin	17.60%	12.84%	8.36%	21.26%	-14.35%
EBITDA	63.73	70.17	74.1	82.91	26.05
EBITDA Margin	37.63%	40.42%	36.07%	42.84%	14.96%
EBIT	61	67.49	70.3	70.66	20.12
EBIT Margin	36.02%	38.87%	34.23%	36.51%	11.55%
Effective Tax Rate	41.15%	37.80%	36.44%	47.59%	76.55%

SEC Filings: 10-K · 10-Q